Insilico from Hong Kong sells cancer drug in $500M deal.
Hong Kong-based AI-driven company sells potential breast cancer drug in deal whose value could exceed US$500 million Insilico Medicine, a Hong Kong-based AI-driven drug discovery company, has sold its preclinical drug candidate